“…Moreover, because the heart rate-diastolic time relation is nonlinear, the decrease in heart rate induced by ivabradine most likely results in an increase in the diastolic part of the cardiac cycle, 25 leading to an enhanced coronary perfusion time and thus increasing myocardial perfusion, especially to the deeper layer. 26 Finally, an increase in coronary perfusion due to HRR would prevent the development of coronary endothelial dysfunction provoked by the long-term decreased perfusion observed in CHF 27,28 and, by preventing local hypoxia, could diminish the local production of cytokines such as interleukin-1, interleukin-6, and tumor necrosis factor-␣, 29 free radicals, 30 and/or vasoconstrictors such as endothelin, 31 all factors implicated in the deterioration of LV function/remodeling and intrinsic tissue structure. Furthermore, in terms of myocardial O 2 demand and tissue protective effects, the improvement in LV filling induced by the decrease in heart rate may diminish the level of sympathetic activity, as suggested by the decrease in noradrenaline plasma levels.…”